Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
CDH18 Biologics Sequence Review Report 2026: Cadherin-18 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH16 Biologics Sequence Review Report 2026: Cadherin-16 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH15 Biologics Sequence Review Report 2026: Cadherin-15 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH12 Biologics Sequence Review Report 2026: Cadherin-12 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH12 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH10 Biologics Sequence Review Report 2026: Cadherin-10 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH13 Biologics Sequence Review Report 2026: Cadherin-13 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH13 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH11 Biologics Sequence Review Report 2026: Cadherin-11 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH11 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CDH1 Biologics Sequence Review Report 2026: Cadherin-1 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CDH1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CD52 Biologics Sequence Review Report 2026: CAMPATH-1 antigen Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CD52 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CD6 Biologics Sequence Review Report 2026: T-cell differentiation antigen CD6 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CD6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL4 Biologics Sequence Review Report 2026: C-C motif chemokine 4 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL8 Biologics Sequence Review Report 2026: C-C motif chemokine 8 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
5
6
7
8
9
>>
1503
>